# Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients

> **NCT06545292** · NA · RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 360 (estimated)

## Conditions studied

- Drug Monitoring

## Interventions

- **DIAGNOSTIC_TEST:** Therapeutic drug monitoring with a dried blood spot and microatainer.

## Key facts

- **NCT ID:** NCT06545292
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-07-01
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545292, "Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06545292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*